Tuesday, December 5, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Medical Oncology Specialist
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Director, Breast Cancer Research Program
Texas Oncology and US Oncology
Dallas, Texas, United States
Medical Director
Womens Clinic
Director, Department of Obstetrics and Gynecology
University Hospital Ulm
Ulm, Germany
Nurse Practitioner
Carol Franc Buck Breast Cancer Center
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California, United States
Professor of Medicine
Head, Medical Oncology Service
Hospital General Universitario Gregorio Marañón
Universidad Complutense
Madrid, Spain
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This educational activity is intended for a global audience of hematology/oncology specialists, surgeons, pathologists, and nurses.
The goal of this activity is for learners to better understand the latest recommendations for risk assessment in hormone receptor (HR)+/human epidermal growth factor receptor 2 (HER2)- early breast cancer and management of patients with high risk; and, further, to improve skills for shared decision making and communication between the interprofessional team and the patient to improve adherence and persistence to oral anti-cancer therapies.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Medical Oncology Specialist
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Director, Breast Cancer Research Program
Texas Oncology and US Oncology
Dallas, Texas, United States
Medical Director
Womens Clinic
Director, Department of Obstetrics and Gynecology
University Hospital Ulm
Ulm, Germany
Nurse Practitioner
Carol Franc Buck Breast Cancer Center
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California, United States
Professor of Medicine
Head, Medical Oncology Service
Hospital General Universitario Gregorio Marañón
Universidad Complutense
Madrid, Spain
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 1.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 9/27/2022
Valid for credit through: 9/27/2023, 11:59 PM EST
processing....
